National Institutes of Health (NIH) researchers have discovered rare antibodies that could inform the development of an ...
Antibodies play a central role in your body’s immune defense. But they’re also nearly ubiquitous in biological research, ...
Co., Ltd. ("Biocytogen", SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. ("Qilu Pharmaceutical") for a fully ...
Teva Pharmaceutical's dreams of a first-in-class autoimmune blockbuster are being kept alive after the Israeli outfit’s ...
Science sleuth’s findings raise questions for researchers working to improve the reliability of commercial antibodies.
Treeline Biosciences, Inc. ("Treeline") today announced a clinical trial collaboration and supply agreement with Roche (SIX: RO, ROP; OTCQX: RHHBY) to evaluate TLN-121, Treeline's BCL6 degrader, in ...
A two-antibody click-chemistry strategy improves targeted chemotherapy delivery to resistant HER2- and EGFR-positive tumors, ...
Researchers at the National Institutes of Health made the breakthrough after studying disease-fighting proteins made by the immune system.
REHOVOT, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ("Purple Biotech" or the “Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy platform designed to ...
British scientists make a significant advance towards a universal vaccine against pneumonia and meningitis caused by ...
A new system to approve medicines faster has been introduced. But barriers facing RSV protections shows why that’s only one ...
Bing Wang, CFO of Akeso, discusses the biotech company’s growth outlook, its “guided missile” strategy combining bispecific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results